Study of blood filter after kidney therapy
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study is for adults who are starting continuous kidney replacement therapy (CRRT) for kidney failure. It looks at how well the filter removes waste, and excludes people on ECMO.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are starting or already on continuous kidney replacement therapy (CRRT).
- You are not on ECMO (a heart-lung bypass machine).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether the lifespan (how long they can be used) of dialysis filters can be optimized during continuous kidney dialysis for very sick adults. If successful, it may improve care and use of dialysis supplies for people with dialysis-dependent kidney injury.
This study looks at two different blood thinners—regional citrate and systemic heparin—used during continuous kidney replacement therapy (CKRT) for acute kidney injury (AKI). It aims to learn which works better and safer.
This study tests a special blood filtration machine (multiFiltratePRO) in children with kidney failure who need continuous dialysis. It aims to see how well the treatment works and if it's safe for younger patients.
This study does a “chart review” of existing dialysis treatment records from 2019. It checks how specific dialysis filters and concentrate products performed and how treatment measurements changed over time.
This study compares different types of dialysis to see which removes waste products (uremic toxins) best from the blood. If you have been on dialysis for at least 6 months and use the same filter for a year, this trial may help find a better way to clean your blood.
This study tests different doses of a continuous blood-filtering treatment for critically ill patients with sudden kidney failure. It may help doctors find the best dose to improve outcomes.
Hear when a new Renal Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.